ArticleBioMed research international2026
Preclinical Evaluation of a Zinc Oxide Nanoparticle-Loaded Amniotic Membrane as a Bioactive Scaffold for Partial-Thickness Burn Healing in Rats.
Article in BioMed research international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Preclinical Evaluation of a Zinc Oxide Nanoparticle-Loaded Amniotic Membrane as a Bioactive Scaffold for Partial-Thickness Burn Healing in Rats.BioMed research international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Burn wound infections continue to be a leading cause of morbidity and mortality despite advancements in medical treatments. Human amniotic membrane and zinc oxide nanoparticles have individually shown promise in enhancing wound healing. This study evaluated the efficacy of a novel composite scaffold made of zinc oxide nanoparticles-impregnated human amniotic membrane for treating second-degree burn wounds. Human amniotic membrane was isolated from cesarean-delivered placentas and loaded with nanoparticles via ultrasonic dispersion. The composite scaffold was characterized using scanning electron microscopy and energy-dispersive x-ray spectroscopy, which confirmed uniform nanoparticle distribution. Human fibroblast cell culture studies demonstrated enhanced cell viability and adhesion in the composite scaffold compared with controls. In a rat model of second-degree burns, the nZnO-impregnated human amniotic membrane significantly improved wound healing, evidenced by faster reepithelialization, reduced inflammation, and complete tissue regeneration by Day 14. These findings suggest that the combination of nZnO and human amniotic membrane offers superior wound healing properties over traditional treatments, with potential applications for burn care. Future studies should explore human trials to further validate the clinical potential of this novel approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.